The healthcare industry is spending billions on healthcare-specific technology, with AI pilots representing 46% of all healthcare investment as hospitals work to turn AI from a board-mandated shiny object into a strategic tool they can scale. However, hospital CFOs increasingly question whether these investments deliver meaningful returns or just pile onto existing technical debt.
CFOs simultaneously face growing pressure from boards to demonstrate measurable ROI while also improving patient and clinician outcomes, making it clear that budget growth doesn’t necessarily translate to easier approvals. As a result, CFOs confront an emerging paradox: more dollars to spend, but far less tolerance for risk and uncertainty.
Persistent cost pressure also tightens ROI expectations, compressing the traditional three-year timeline to as little as 12–18 months. Today, 51% of CFOs require returns that exceed 110% within 18 months, meaning full recovery of the initial investment plus an additional 10% in financial gain. About one in five (19%) expect returns greater than 120% within just 12 months. In other words, even as investment in innovation rises, tolerance for failure and ambiguity drops sharply.
For financial leaders, accountable, outcomes-driven investment models now require a clearer understanding of where losses originate, why pilots fail, and how organizations deliver value consistently. This shift begins by addressing a problem many hospitals still underestimate: the operational failures that quietly drain daily margins.
Hidden operational failures are a major, underreported cost driver
Operational failures like temperature excursions or manual compliance reporting errors drive compliance risk and financial loss, while also going largely unnoticed until disruption occurs. These failures unfold in high-risk areas like pharmaceutical storage, server rooms, and blood and biological product storage, remaining invisible until they emerge in the form of asset loss, regulatory exposure, or patient safety risks.
Imagine you’re a hospital pharmacist who discovers sustained temperature deviation in pharmaceutical storage. Defective refrigeration and freezer conditions mean more than product loss, as the hospital system now must pay for expedited replacement and shipping costs as well. On top of this, downstream operational strain negatively impacts both clinician workflows and patient care. Even small breakdowns add up, with nearly one in four hospitals reporting losses exceeding $1M annually due to preventable operational failures.
Historically, many organizations chalk these losses up to “the cost of doing business,” as visibility into the true financial impact remains limited. In practice, CFOs and CIOs often lack a system-wide view of these costs, with expenses spread across departments and rarely tied back to a specific incident. But as scrutiny on every dollar intensifies, blind spots are harder to ignore.
As financial pressure intensifies, CFOs increasingly identify, quantify, and target these losses for elimination. But even as leaders work to eliminate hidden losses, many remain wary of the technologies meant to prevent these risks.
Failed tech pilots force a rethink of innovation strategy
While hidden operational losses drive cost pressure, failed technology pilots exacerbate CFO skepticism. Fifty-seven percent (57%) of CFOs report that half or more of technology pilots fail to deliver meaningful results. As investments in technology rise, CFOs are discovering that what works in a controlled demo environment does not always translate into real-world scenarios. This leaves CIOs with stalled initiatives and CFOs accountable for the spend.
Failures can span clinical, operational, and administrative areas alike, undermining confidence in new technology and investments. However, the issue is rarely technology itself. Many teams launch pilots opportunistically and without clear alignment to enterprise priorities or a plan to scale. The result? CFOs want less value, a shift away from pilot-heavy models, and demands for faster proof of value and paths to scale.
Despite high failure rates among tech pilots, innovation remains a priority, but measuring value has shifted to stricter, outcome-driven conditions. This movement is redefining what CFOs now want from technology investments: fewer disconnected tools, more scalable platforms, and clearer ownership of outcomes.
CFOs prioritize platforms and need internal champions to deliver value
As CFOs pursue high-impact investments, they increasingly turn to platform-based solutions that reduce tool sprawl and improve scalability. Similar to EHR systems that evolved from point solutions into enterprise platforms, AI pilots will likely simplify into more uniformed, platform-based approaches. However, platforms alone do not guarantee value. They require strong internal ownership, clear strategic alignment, and defined outcomes to succeed.
Organizations increasingly need “platform champions,” or individuals who drive adoption alignment, and accountability. Champions span CIOs, CFOs, or operational positions, but ideally serve as the bridge between finance and IT to eliminate the “black box” perception around technology spend. By embedding finance more closely into IT decision-making, champions strengthen alignment and ensure effective adoption.
Without a clear point of contact around new investments, even high-potential platforms become underutilized or fragmented, simply adding to technical debt rather than reducing it. Moving the needle with platform investments requires strong leadership structures and governance models that ensure value materializes across departments.
A new mandate for CFOs
As the industry continues to pour money into AI and other emerging technologies, a more disciplined era of healthcare technology investment is taking shape. This era is defined by tighter ROI expectations, lower tolerance for risk, and greater accountability for outcomes.
For CFOs, the opportunity lies beyond just new innovation. Smart financial leaders will focus on eliminating the hidden losses that erode margins and impact care delivery. This shift requires proactive, risk-informed decision-making grounded in actionability, alignment, and execution.
Hospitals that connect technology investments to measurable financial, operational, and clinical outcomes are best positioned to thrive in the coming years. On the other hand, those who fail to do so risk higher spending while losing just as much beneath the surface. To connect measurable outcomes with technology investments, CFOs must rethink how they approach innovation, ushering in a new era focused on better patient experiences.
Photo: Andriy Onufriyenko, Getty Images
Guy Yehiav is the President of SmartSense by Digi. He is a recognized thought leader in retail, CPG, supply chain, and complex manufacturing with a proven track record of success in M&A, Customer Success, B2B enterprise software solutions, SaaS metrics, and AI & IoT solutions. Guy most recently served as the GM and VP of Zebra Analytics. He strategized, developed and delivered the overall AI, machine learning, and analytics strategy by driving M&A and the development of enterprise solutions.
Edward Marx is a pioneering force in healthcare technology, renowned for his transformative leadership as a former global CIO for institutions including the Cleveland Clinic, NYC Health + Hospitals, Texas Health Resources, and University Hospitals, and his current role as CEO of Marx Advisory. With a career dedicated to bridging the critical gap between healthcare buyers and sellers, he leverages his unparalleled executive experience to foster innovation, drive digital transformation, and improve patient outcomes.
This post appears through the MedCity Influencers program. Anyone can publish their perspective on business and innovation in healthcare on MedCity News through MedCity Influencers. Click here to find out how.
